RunawayRx's Dose of Reality series helps keep the public up-to-date on pharma's latest drug pricing schemes and major happenings around the industry. Our most recent edition highlights the role of patents in keeping prices high, California's plan to expand access to Hepatitis C drugs, a new survey that reveals the public's failing trust in pharma, and research results that call for more drug price transparency.
|